CROLLL - Indication expertise / Experiences
  • Crolll

Indication expertise / Experiences

Our continuously expanding portfolio of indications includes:

  • Oncology: chronic myeloid leukemia (CML), acute myeloid leukemia (AML), non-small cell lung cancer (NSCLC), breast cancer, gastrointestinal stromal tumors (GISTs), glioblastoma, medulloblastoma, malignant melanoma, carcinoid syndrome, morbus cushing, acromegaly, tuberous sclerosis, pancreatic, colorectal and renal carcinoma
  • Central nervous system: multiple sclerosis, fragile X syndrome, attention deficit and hyperactivity disorder (ADHD), Parkinson´s disease, Alzheimer´s disease, optic neuritis
  • Cardiology: hypertension, pulmonary arterial hypertension (PAH), acute heart failure, arrhytmias
  • Dermatology: psoriasis, urticaria
  • Immunology: rheumatoid arthritis, spondylitis ankylosans, psoriasis arthritis, graft-versus-host disease (GVHD), pollen allergy
  • Transplantation: kidney, lung, liver, heart
  • Infectious diseases: H1N1 influenza, hepatitis c virus (HCV), chronic pneumonia
  • Ophthalmology: age-related macular degeneration (AMD), diabetic macular edema (DME), retinopathy of prematurity, pathologic myopia, retinal vein occlusion (RVO)
  • Pneumology: chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis
  • Metabolism: Graves´ disease, diabetes mellitus, gout, cystic fibrosis
  • Musculoskeletal: bone marrow edema syndrome
  • Medical devices/in vitro diagnostics: orthoses, surgical meshes, MitraClip®, ECG, TAVI, software applications


Services Projectmanagement eCRF-Design and Management Datamanagement / Biometry Indication expertise / Experiences Monitoring Regulatory Affairs Medical/Scientific Writing